Back
VCYT long @ 44.65

Entry is the price this call is measured from — not a trade anyone executed.

37.12 41.19 45.25 49.31 53.37 Aug 26 Sep 11 Sep 28 Oct 13 Oct 28 apesalpha.com ENTRY 44.65
Entry 44.65 At close 50.31 +12.7% vs entry 16 sessions since the post 2026-08-26 → 2026-10-28

This is a disclosed purchase, not a prediction — nothing here is a recommendation by the filer. The figure is measured from the entry price, which is the closing price on the trade date; this post is dated the first session after the filing became public, typically weeks later. So the move above covers a period before the disclosure existed, and is not a return anyone following this account could have captured.

ARK bought 389,509 shares of VCYT for ARKG.

  1. The trade: 0.75% of that fund, on 6 October 2026 — roughly $17.4m at that day’s close.
  2. The entry: VCYT's close on 6 October 2026, $44.65. ARK discloses the fund, date, direction and share count -- never the price it paid -- and the notification posts after the close, so this is the closing print on the day they traded, not their actual fill. The first moment anyone reading could act on it was the next open.

Also bought that session: AMZN at 256.29 (0.42% of ARKW), GENI at 6.22 (0.30% of ARKF), META at 738.88 (0.26% of ARKW), AVAV at 143.54 (0.25% of ARKX), XYZ at 76.54 (0.24% of ARKF), LUNR at 15.06 (0.17% of ARKX), JOBY at 5.78 (0.16% of ARKQ), AUR at 5.75 (0.15% of ARKQ), KYMR at 105.98 (0.09% of ARKG), PONY at 6.13 (0.05% of ARKQ), BIDU at 87.05 (0.05% of ARKQ), FRNM at 16.36 (0.02% of ARKG), NRIX at 22.60 (0.02% of ARKG). Each priced the same way — the close on the day ARK traded it.

ARK’s most recent published holdings, as of the 5 October 2026 close, put ARKK’s position at 2,041,895 shares of VCYT — 1.02% of the fund.

Risk: ARK's file covers portfolio adjustments the investment team made -- it excludes creation and redemption activity, which moves an ETF's share counts without anyone deciding anything. Sales are not posted here: trimming a position is an exit, not a short. An automated tracker of public ARK Invest disclosures, not a recommendation. Not run by or affiliated with ARK Invest or Cathie Wood.

Mentioned AMZN GENI META AVAV
· Tue, 06 Oct · · 33 views 10 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.